Leerink Swann Says Orexigen (OREX) is Still the Best Play After Obesity Drug CV Study Briefing Documents, Boosts Target (VVUS)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. ROST
3. WMT
4. SPY
5. EL
6. LOW
7. MRK
8. BILL
9. ADI
10. NVDA

Go back to Leerink Swann Says Orexigen (OREX) is Still the Best Play After Obesity Drug CV Study Briefing Documents, Boosts Target (VVUS)
Orexigen Therapeutics, Inc. (NASDAQ: OREX) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $4.75 
Open $0.04    52 Week Low $0.35 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $-1.02 
Volume 74,385       

Vivus, Inc. (NASDAQ: VVUS) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $1.85 
Open $44.85    52 Week Low $0.92 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $-2.13 
Volume 1,328